Squawk on the Street podcast

Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24

0:00
3:37
Reculer de 15 secondes
Avancer de 15 secondes

Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake  

CNBC Investing Club Disclaimer

D'autres épisodes de "Squawk on the Street"